Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 43Other hematologic neoplasm 34Plasma cell 12Myeloid 5Thoracic 3Head & Neck 3Gynecologic 3Classical hematology 3CNS 3Dermatologic 1Breast 1

Conditions

Breast Neoplasms 27Ovarian Neoplasms 15Triple Negative Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 13Melanoma 10Neoplasm Metastasis 9Colorectal Neoplasms 8Stomach Neoplasms 7Pancreatic Neoplasms 7Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Urogenital Neoplasms 4Multiple Myeloma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Endometrial Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Prostatic Neoplasms 2Osteosarcoma 2Lymphoma 2Liver Neoplasms 2Kidney Neoplasms 2Glioblastoma 2Fallopian Tube Neoplasms 2Esophageal Neoplasms 2Thyroid Carcinoma, Anaplastic 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cyclophosphamide 6Radiotherapy 5olaparib 3exemestane 3Paclitaxel 3Letrozole 3Itraconazole 3Gemcitabine 3Fulvestrant 3Carboplatin 3Blood Specimen Collection 3palbociclib 2fludarabine phosphate 2eribulin 2avelumab 2abemaciclib 2Therapeutics 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Mastectomy 2Flow Cytometry 2Filgrastim 2Exercise 2Everolimus 2Etoposide 2Dasatinib 2Cetuximab 2Carmustine 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × fludarabine × Breast × Clear all
NCT06347068 2026-04-22

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
42 enrolled
Breast

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡